Delivery of a drug via subconjuctival or periocular delivery of a prodrug in a polymeric microparticle

Details for Australian Patent Application No. 2004260645 (hide)

Owner Allergan, Inc.

Inventors Olejnik, Crest; Hughes, Patrick M.

Agent Davies Collison Cave

Pub. Number AU-B-2004260645

PCT Pub. Number WO2005/011741

Priority 10/617,468 10.07.03 US

Filing date 7 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 11 March 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/203 (2006.01)

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/011741 Priority application(s): WO2005/011741

11 March 2010 Application Accepted

  Published as AU-B-2004260645

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260648-Electrosurgical generator

2004260643-Particulate inorganic solids treated with organophosphinic compounds